Transaction · 0002048500-26-000002

Mensinger Mike

Mensinger Mike, CPO, reported an open-market or private sale at Beta Bionics, Inc. involving 7200.000000 shares for an estimated $212832.00. Reported holdings after the transaction were 83552.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCPO
BBNXBeta Bionics, Inc.
Filing timeJan 05
Trade dateJan 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$29.25
Pre-filing
1mo ago +1.0%1w ago +1.0%1d ago +1.0%
Returns since
7d +0.0%30d -53.2%90d -65.8%180d -42.7%1y -34.8%

BBNX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BBNX since 2026-01-05Filed 242 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002048500-26-000002
Common Stock
Transaction date
Jan 02, 2026
Filed Jan 05, 2026, 11:05 PM · 3d delay
Shares
7.20k sh
$2.95k per share
Estimated value
-$21.2M
Computed from shares × price
Holdings after
83.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Product Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.

  2. F2

    The weighted average sale price for the transaction reported was $29.56 and the range of prices were between $29.05 and $30.02. Upon request by the SEC staff, the Issuer, or any security holder of the…

  3. F3

    The weighted average sale price for the transaction reported was $30.1969 and the range of prices were between $30.10 and $30.52. Upon request by the SEC staff, the Issuer, or any security holder of t…

Original filing · 0002048500-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BBNX